Concepedia
Statistics
Publications
39
Citations
1.7K
H-Index
25
Active since
1980
Affiliations
Ajinomoto (United States)(Current)
Ajinomoto (Japan)
Suzuki (Japan)
The University of Tokyo
Exelixis (United States)
Yutaka Matsuda is an author at Ajinomoto (United States) specializing in pharmacy, antibody conjugates, and antibody engineering.
Publications per year
1980–2025
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
Thomas Schlange, Yutaka Matsuda, Susanne Lienhard et al. · Breast Cancer Research · 2007 · 229 citations · Full text
Life Sciences, Genetics, Oncology +17
Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity
Nobuya Ishii, Naoki Harada, Eric W. Joseph et al. · Cancer Research · 2013 · 166 citations
Medicine, Oncology, Pharmacology +16
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
Yutaka Matsuda, Thomas Schlange, Edward J. Oakeley et al. · Breast Cancer Research · 2009 · 156 citations · Full text
Medicine, Cancer Biology, Oncology +17
AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies
Kei Yamada, Natsuki Shikida, Kazutaka Shimbo et al. · Angewandte Chemie International Edition · 2019 · 109 citations
Pharmacy, Chemical Biology, Medicinal Chemistry +17
Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates
Yutaka Matsuda, Brian A. Mendelsohn · Chemical and Pharmaceutical Bulletin · 2021 · 72 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmaceutics +16
1–5 of 39